Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03665688 · ClinicalTrials.gov registry record · NA
Comparing Outpatient to Inpatient Cervical Ripening Using Dilapan-S®
A NA study, sponsored by The University of Texas Medical Branch, Galveston.
- Completed
- Registry status
- NA
- Development phase
- 338
- Enrollment target
NCT03665688: Completed NA study, sponsored by The University of Texas Medical Branch, Galveston.
NCT03665688 is a NA study that has completed, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 338 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (76% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03665688, a NA study, has completed, sponsored by The University of Texas Medical Branch, Galveston.
- COMPLETED
- Registry status
- NA
- Development phase
- 338 participants
- Enrollment target
Study Summary
The target population for our study is women who present for induction of labor. If there is a decision by the obstetrical team to place a mechanical dilator for cervical ripening, the obstetrical team will notify the research staff so that the patient may be screened for the study. If the subject is eligible for the trial, written informed consent will be obtained by person-to-person contact. The PI, study coordinator, or a collaborator will be responsible for the informed consent procedure. After informed consent is obtained and Dilapan-S is placed, the patient will be randomized to the Outpatient or the Inpatient group.
Primary Outcome
Rate of hospital stay longer than 48 hours (from admission to discharge)
Interventions
- DEVICE Outpatient Dilapan-S
- DEVICE Inpatient Dilapan-S
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 338 participants |
| Start Date | 2018-11-07 |
| Est. Completion | 2021-11-05 |
| Phase | NA |
What the finished NCT03665688 record still lists
NCT03665688 is an interventional study that assigns participants to a tested intervention. The registered 338 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (76% lower).
The record links to 0 conditions, and to 2 interventions - of which Outpatient Dilapan-S is the first listed.
NCT03665688 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03665688 about?
NCT03665688 is a clinical study titled "Comparing Outpatient to Inpatient Cervical Ripening Using Dilapan-S®". The target population for our study is women who present for induction of labor. If there is a decision by the obstetrical team to place a mechanical dilator for cervical ripening, the obstetrical team will notify the research staff so that the patient may be screened for the study. If the subject i...
What is the current status of trial NCT03665688?
This trial is currently completed. It is a NA study. The enrollment target is 338 participants. The study started on 2018-11-07. Estimated completion is 2021-11-05.
What interventions are being tested in trial NCT03665688?
The interventions under investigation include: Outpatient Dilapan-S (DEVICE), Inpatient Dilapan-S (DEVICE).
Who is sponsoring clinical trial NCT03665688?
This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03665688's enrollment target sits among peer trials
338 305th of 2000 higher than 1,696 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03253263 · 338 participants · Phase 2
A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants
- NCT05658731 · 338 participants · NA
Cognitive Outcomes After Brain Substructure-informed Radiation Planning in Pediatric Patients
- NCT06022939 · 338 participants · Phase 3
Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis
- NCT04176172 · 340 participants · Phase 3
Optimizing Tobacco Use Treatment for PLWHA
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI